Age UK Dementia MCST Programme Evaluation
Age UK Dementia MCST Programme Evaluation
1
1
•
•
Age UK Dementia MCST Programme Evaluation
2
•
•
*one project captured baseline and final survey data only
Age UK Dementia MCST Programme Evaluation
3
Age UK Dementia MCST Programme Evaluation
5
Age UK Dementia MCST Programme Evaluation
6
“ ”
“ ”
“ ”
“ ”
Age UK Dementia MCST Programme Evaluation
7
“ ”
“ ”
“ ”
“ ”
“ ”
“ ”
Age UK Dementia MCST Programme Evaluation
8
“ ”
“ ”
“ ”
“”
“ ”
Age UK Dementia MCST Programme Evaluation
9
“ ”
“ ”
90
85
DEMQOL Average (28-112)
Final
Baseline
Age UK Dementia MCST Programme Evaluation
10
Age UK Dementia MCST Programme Evaluation
11
Age UK Dementia MCST Programme Evaluation
12
N=36
Age UK Dementia MCST Programme Evaluation
13
Age UK Dementia MCST Programme Evaluation
14
“ ”
“ ”
“ ”
“ ”
“ ”
“ ”
Age UK Dementia MCST Programme Evaluation
15
“
”
“ ”
“ ”
“
”
“
”
Age UK Dementia MCST Programme Evaluation
16
“ ”
“”
“ ”
“ .”
“.”
Age UK Dementia MCST Programme Evaluation
17
“”
“ ”
“ ”
“ ”
“ ”
“ ”
“ ”
Age UK Dementia MCST Programme Evaluation
18
Age UK Dementia MCST Programme Evaluation
19
Age UK Dementia MCST Programme Evaluation
20
“ ”
Age UK Dementia MCST Programme Evaluation
21
“ ”
“ ”
Age UK Dementia MCST Programme Evaluation
22
“ ”
Age UK Dementia MCST Programme Evaluation
23
Age UK Dementia MCST Programme Evaluation
24
Age UK Dementia MCST Programme Evaluation
25
Age UK Dementia MCST Programme Evaluation
26
Age UK Dementia MCST Programme Evaluation
27
Age UK Dementia MCST Programme Evaluation
28
9
Age UK Dementia MCST Programme Evaluation
Age UK Dementia MCST Programme Evaluation
Age UK Dementia MCST Programme Evaluation
Age UK Dementia MCST Programme Evaluation
Age UK Dementia MCST Programme Evaluation
Age UK Dementia MCST Programme Evaluation
EVALUATION OF MAINTENANCE COGNITIVE STIMULATION THERAPY PROGRAMME
INFORMATION FOR CARERS
The programme the person you care for is attending is being evaluated by Brightpurpose, an independent research organisation, to help Age UK understand what difference the programme makes to people with dementia and their carers. Age UK are doing this because they want to be able to inform future decision making about provision of services for people with dementia so that at a national scale these valuable services can be provided efficiently and effectively. They want to be able to change things so that services like these can as good as it can be; and that no matter where they are in the country families living with dementia will have access to this kind of service. We will be asking the person you care for to take part in some interviews over the course of the programme to see how things are changing for them. These will take place outside of the sessions time so that they do not interfere with their activities. The staff can talk to you more about what’s involved with that process if you have any questions. We would also like to get some feedback from you, to understand what difference having this service available makes to your life. We have a short self-completion survey which we would like you to complete at the beginning, midpoint and end of the programme. Staff will facilitate this and collect in your completed surveys. The information you provide is confidential and we will anonymise your answers before we pass them to the research organisation. Your personal details will be held securely and not passed on to any third party. We know time is precious but this is a really important piece of work so we hope you can spare a few minutes to complete the survey. Please sign below if you consent to taking part and complete the survey attached. Name: ………………………………………………….. Carer No: ……………………(to be completed by staff)
I understand what I am being asked to do and I consent to participating in the evaluation as described to me. Signed: …………………………………………………
Thank you for taking the time to complete this short questionnaire. Please read the following statements carefully and indicate your response to each statement by putting a cross through the number which reflects how you feel.